Inside the Crucial Conversations Shaping the Future of the Bioeconomy

Hi ,

In an era where synthetic biology is rewriting life’s blueprint, navigating biosecurity and bioethical complexities has never been more crucial. While innovations promise breakthroughs in biofuels, medicine, and sustainable materials, safeguarding against potential misuse and unintended consequences remains paramount. Policymakers and regulators must develop informed, resilient frameworks that balance innovation with responsibility. The sustainability and security of the emerging bioeconomy ultimately hinge on careful governance that anticipates both the immense promise and potential pitfalls of harnessing biology.

At SynBioBeta 2025, these critical conversations will come alive as industry leaders, policymakers, and innovators gather to chart the future of the bioeconomy and tackle pressing questions around biocontainment. Attendees will explore the trajectory of the U.S. bioeconomy—reflecting on key lessons learned and envisioning future possibilities—as well as the technical and ethical intricacies surrounding the deployment and regulation of engineered microbes. Don’t miss this opportunity to engage in discussions shaping the sustainable and secure advancement of synthetic biology.

Engineering Tomorrow: DARPA’s Push into the Frontier of Synthetic Biology

Through relentless ideation and commercial-minded partnerships, DARPA BTO is aiming to transition scientific marvels from lab prototypes into real-world production

Building a Synthetic Biology Future in the Land Down Under

Government policy support for domestic manufacturing and sustainability is fueling Australia’s synthetic biology ecosystem

The Influence of Synthetic Biology on National Bioeconomy Strategies

The synthetic biology industry is commonly hailed as the most promising way to advance the global bioeconomy, but how do the policymakers perceive this potential, and should they integrate it into the national bioeconomy strategies

Track Chair

Bioeconomy & Biosecurity Sessions

Related Sponsors

The Next Asilomar Moment: Why Genetic Innovation Needs a Regulatory Revolution

Fifty years after the Asilomar Conference, outdated biotech regulations are stalling innovation—will we get a 21st-century reset?

UK at Risk of Losing Engineering Biology Lead, Lords Report Warns

Engineering biology could revolutionize industries, but the UK’s failure to scale innovation is holding it back

National University of Singapore Advances a Synthetic Biology-Driven Future

Investing in Research, Technology Transfer, and Partnerships to Establish Singapore as a Global Leader in Synthetic Biology

ARPA-H Unveils Program to Revolutionize Drug Safety and Efficacy Testing

The new program aims to slash drug development failure rates and enhance efficacy forecasts before clinical trials commence

How do we build a resilient and secure bioeconomy? At SynBioBeta 2025 this May, we’ll tackle the technologies, policies, and investment strategies shaping the future of biosecurity and sustainable biomanufacturing. From securing biological assets and fortifying supply chains to scaling production and mitigating emerging threats, this is where science meets strategy. Don’t just anticipate the future—help safeguard and build it. Join us in San Jose, May 5-8, to be part of the conversation.